Janux Therapeutics, Inc. (JANX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 47.10 |
| Open | 47.08 |
| Bid | 47.33 x 200 |
| Ask | 47.61 x 200 |
| Day's Range | 46.61 - 48.23 |
| 52 Week Range | 5.65 - 58.69 |
| Volume | |
| Avg. Volume | 941,188 |
| Market Cap | 2.448B |
| Beta (5Y Monthly) | 4.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.32 |
| Earnings Date | May 10, 2024 - May 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 58.29 |
ZacksJanux (JANX) Rises Almost 50% in a Week on Buyout Rumors
Janux (JANX) stock surges after some reports claim that the company is exploring opportunities for a potential sale following buyout offers from big pharma companies.
ZacksJanux Therapeutics (JANX) is on the Move, Here's Why the Trend Could be Sustainable
If you are looking for stocks that are well positioned to maintain their recent uptrend, Janux Therapeutics (JANX) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Investor's Business DailyBiotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
Biotech stocks heated up Thursday as Novartis scooped up a licensing pact with Arvinas and Janux was said to be exploring strategic options.
© 2024 Yahoo. All rights reserved.